Storage Condition
Refer MSDS for complete information
Synonyms
9-Monodemethyl Minocycline, 4769-39-5
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
9-Monodemethyl Minocycline is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
9-Monodemethyl Minocycline usage and description
9-Monodemethyl Minocycline is a semi-synthetic tetracycline antibiotic that is commonly used in the treatment of various bacterial infections. It is a derivative of minocycline, which is a broad-spectrum antibiotic that is effective against a wide range of bacteria, including gram-positive and gram-negative bacteria.
Chemically, 9-Monodemethyl Minocycline is a tetracycline derivative that differs from minocycline by the presence of a methyl group on the nitrogen atom of the dimethylamino group. This modification enhances the antibiotic activity of the molecule by increasing its lipophilicity and improving its ability to penetrate bacterial cell membranes.
9-Monodemethyl Minocycline is typically administered orally, and its peak plasma concentration is reached within 2-4 hours of ingestion. The drug is metabolized in the liver and excreted in the urine and feces. Its half-life is approximately 14-22 hours.
The drug is effective against a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, and acne. It is also used in the treatment of Lyme disease, Rocky Mountain spotted fever, and other tick-borne illnesses.
While 9-Monodemethyl Minocycline is generally well-tolerated, it can cause side effects in some patients, including nausea, vomiting, diarrhea, and photosensitivity. It can also interact with other medications, so patients should always inform their healthcare provider of any other drugs they are taking.
